A carregar...

Cisplatin is retained in the cochlea indefinitely following chemotherapy

Cisplatin chemotherapy causes permanent hearing loss in 40–80% of treated patients. It is unclear whether the cochlea has unique sensitivity to cisplatin or is exposed to higher levels of the drug. Here we use inductively coupled plasma mass spectrometry (ICP-MS) to examine cisplatin pharmacokinetic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Commun
Main Authors: Breglio, Andrew M., Rusheen, Aaron E., Shide, Eric D., Fernandez, Katharine A., Spielbauer, Katie K., McLachlin, Katherine M., Hall, Matthew D., Amable, Lauren, Cunningham, Lisa L.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5698400/
https://ncbi.nlm.nih.gov/pubmed/29162831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-017-01837-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!